𝔖 Bobbio Scriptorium
✦   LIBER   ✦

386 High-dose chemotherapy with stem cell support in high-risk primary breast cancer. An analysis of the effect on overall survival the Danish experience from a comparison study

✍ Scribed by T. Palshof; S. Werner Hansen; C. rose; S. Møller; P. Hokland; I. Svane; F. Hansen; L. Jarlbæk; H. Mouridsen

Book ID
118620560
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
170 KB
Volume
1
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P53 is the strongest predictor of surviv
P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support
✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Erich Sol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 3 views

## Abstract Our purpose was to determine the predictive value of tumor biologic parameters in patients with HRPBC who received HDCT with ASCT as first‐line treatment. From September 1992 to May 2000, 149 stage II or III HRPBC patients were enrolled in a single‐arm trial using a tandem HDCT regimen